Reprint

Plasma Biology

Edited by
September 2021
378 pages
  • ISBN978-3-0365-1568-7 (Hardback)
  • ISBN978-3-0365-1567-0 (PDF)

This book is a reprint of the Special Issue Plasma Biology that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

Irving Langmuir coined the name “plasma” to describe an ionized gas back in 1927. Just over 90 years later, plasma technology is becoming increasingly important in our daily life. For example, in the medical field and dentistry, plasma is used as a method of disinfection and sterilization. Moreover, additional potential novel applications of this technology in different forms of therapy have been proposed. In the agricultural sector, plasma technology could contribute to higher crop yields by enhancing seed germination and the growth of plants, as well as the preservation of foods by disinfection. Plasma technology could also be utilized in environmental applications, including water treatment and remediation, as well as treatment of exhaust gases. Although recent extensive studies have uncovered the broad potential of plasma technology, its mechanisms of action remain unclear. Therefore, further studies aimed at elucidating the molecular mechanisms of plasma technology are required. This book is composed of original articles and reviews investigating the molecular mechanisms of plasma biology. Relevant areas of study include applications in plasma medicine, plasma agriculture, as well as plasma chemistry. Studies on potential therapeutic approaches using plasma itself and plasma-treated solutions are also included.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
cold jet atmospheric pressure plasma; reactive oxygen and nitrogen species; backbone cleavage; hydroxylation; carbonyl formation; cold atmospheric plasma; autophagy; silymarin nanoemulsion; PI3K/mTOR pathway; cold atmospheric plasma; wound healing; oncology; regenerative medicine; plasma; atmospheric pressure plasma jets; large-scale imaging; machine learning; cancer treatment; cellular imaging; reactive oxygen species; cold atmospheric plasma; mesoporous silica nanoparticles; biomaterials; bone regeneration; cytotoxicity; proliferation; osteogenic differentiation; plasma-activated medium; TRAIL; DR5; apoptosis; ROS/RNS; atmospheric-pressure plasma; titanium; amine; osteogenic differentiation; mesenchymal stem cells; antibiotic resistant bacteria; antibiotic resistance gene; disinfection; E. coli; inactivation; plasma; sterilization; apoptosis; cell migration; cold atmospheric plasma; endothelial cells VEGF; cold atmospheric plasma; gynaecological oncology; vulva cancer; risk factors; plasma tissue interaction; premalignant lesions; cancer development; patient stratification; individualised profiling; predictive preventive personalised medicine (PPPM/3PM); treatment; Candida albicans; cold plasma treatment; genome; hydrolytic enzyme activity; carbon assimilation; drug susceptibility; cold atmospheric plasma; malignant melanoma; acidification; nitrite; acidified nitrite; nitration; membrane damage; CAP; cancer; cold atmospheric pressure plasma; hydrogen peroxide; hypochlorous acid; moDCs; peroxynitrite; reactive oxygen and nitrogen species; RNS; ROS; non-thermal plasma; reactive oxygen and nitrogen species; biological activity; breast cancer; solution plasma process; aqueous solutions; chitin; chitosan; degradation; deacetylation; non-thermal atmospheric pressure plasma; reactive oxygen and nitrogen species; Pectobacteriaceae; Dickeya spp.; Pectobacterium spp.; antibacterial; plant protection; agriculture; selective cancer treatment; cold atmospheric plasma; hydrogen peroxide; reaction network; mathematical modeling; n/a; Mdm2–p53; plasma treatment; molecular dynamic (MD) simulations